Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Volume: 9 Issue: 3
Author(s): Sanaa M. Kamal, Louise Warnich, Lynnette R. Ferguson, Sanjeeva Srivastava, Sandipan Ray, Denise Avard, Yann Joly, Michael Le Huynh, Madeline Page, Mario Masellis, Edward S. Dove, David Gurwitz and Vural Ozdemir
Affiliation:
Keywords: Africa, essential diagnostics model list, essential medicines, global public health, pharmacogenomics research funding and development aid, political determinants of health, postgenomics personalized medicine, women's health, Human Genome Sequence, Polymorphism
Export Options
About this article
Cite this article as:
M. Kamal Sanaa, Warnich Louise, R. Ferguson Lynnette, Srivastava Sanjeeva, Ray Sandipan, Avard Denise, Joly Yann, Le Huynh Michael, Page Madeline, Masellis Mario, S. Dove Edward, Gurwitz David and Ozdemir Vural, Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health), Current Pharmacogenomics and Personalized Medicine 2011; 9 (3) . https://dx.doi.org/10.2174/187569211796957511
DOI https://dx.doi.org/10.2174/187569211796957511 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Nanosystems in Drug Targeting: Opportunities and Challenges
Current Nanoscience Targeting Notch Pathway in Cancer Diagnostics and Therapeutics: An Emerging Approach
Recent Patents on Anti-Cancer Drug Discovery Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Current Drug Metabolism Brain MR Image Classification for Glioma Tumor detection using Deep Convolutional Neural Network Features
Current Medical Imaging Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics
Current Pharmaceutical Biotechnology Plumbagin Inhibits Breast Tumor Bone Metastasis and Osteolysis by Modulating the Tumor-Bone Microenvironment
Current Molecular Medicine Gold Nanoparticles; Potential Nanotheranostic Agent in Breast Cancer: A Comprehensive Review with Systematic Search Strategy
Current Drug Metabolism Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer
Current Drug Delivery Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases
Current Drug Metabolism Epigenetic Modifications as Therapeutic Targets
Current Drug Targets <i>In Silico</i> Study of Potential Cross-Kingdom Plant MicroRNA Based Regulation in Chronic Myeloid Leukemia
Current Pharmacogenomics and Personalized Medicine Pentacyclic Triterpenoids and Their Saponins with Apoptosis-Inducing Activity
Current Topics in Medicinal Chemistry The Role of Capecitabine in the Management of Tumors of the Digestive System
Reviews on Recent Clinical Trials Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
Current Drug Targets Synthetic and Biological Attributes of Pyrimidine Derivatives: A Recent Update
Current Organic Synthesis